The current review summarises the role of PAI-1 in impaired fibrinolysis in diabetes and highlights strategies to modulate PAI-1 levels or activity as a mean to improve the fibrinolytic process and reduce thrombosis risk. The gene discussed is SERPINE1; the disease is diabetes mellitus.